grid-line

mybacs

Research-driven direct-to-consumer (DTC) company specializing in the human microbiome. Mybacs aims to revolutionize the market around intestinal healthcare by offering products that contribute to the daily well-being of their customers, differentiating itself through a focus on scientific research and innovation. The primary target demographic includes health-conscious individuals seeking to improve their gut health and overall wellness.
14.8K
Volume
+1900%
Growth
exploding